August 17–21, 2025, Washington, DC, USA - Visit us at Booth 2230.
Read More
Tel:
Email:
Toggle navigation
Home
Technology
Drug Delivery Platform
Sensitive DNA/RNA Synthesis Platform
Services
DNA/RNA Modification
2'-Omethyl RNA Bases
Amino Modifiers
Base Modifications
Chain Terminators
Degenerate Bases
Peptide Nucleic Acid PEGylation
Phosphorylation
Spacer Modifiers
Standard DNA Bases
Standard RNA Bases
sgRNA Services
Prime Editing Guide RNA (pegRNA) Synthesis Service
sgRNA and Cas9 Complex - Ribonucleoprotein (RNP) Synthesis
sgRNA Delivery Service
sgRNA Design Service
sgRNA Library Construction Service
sgRNA Modification Service
sgRNA Vector Construction Service
Oligonucleotides Services
Custom PNA Oligonucleotides Synthesis
Custom DNA Oligonucleotides Synthesis
Custom cDNA Synthesis
pDNA Synthesis
Custom RNA Oligonucleotides Synthesis
Custom Acp3U Modified RNA Synthesis
Custom Circular RNA Synthesis
Custom dsRNA Synthesis
Custom miRNA Synthesis
Custom Self Amplifying RNA Synthesis
Custom sgRNA Synthesis for CRISPR/Cas9
Custom Small Activating RNA Synthesis
Custom ssRNA Synthesis
Custom Piwi Interacting RNA (piRNA) Synthesis
Custom mRNA Synthesis
mRNA 3'-end Processing
mRNA Capping
mRNA Purification
Nucleotide Modifications of mRNA
Custom Oligo Synthesis
Custom Circular Oligonucleotide Synthesis
Custom Degenerated Oligo Synthesis
Custom Plate Oligonucleotide Synthesis
Hybrid Oligonucleotides Synthesis
Large Scale Oligonucleotides Synthesis
Long Oligonucleotide Synthesis
NGS Oligo Synthesis
Oligo Pool Synthesis
Short Oligo Synthesis
Solid Phase Oligonucleotide Synthesis
Trimer Oligos Synthesis
Oligo Labeling Modifications
2'-Modifications
Acridine Labeling of Oligonucleotides
Backbone Modifications
Biotin Labeling of Oligonucleotides
Cholesterol Labeling of Oligonucleotides
Cyanine Labeling of Oligonucleotides
DNP Labeling of Oligonucleotides
Ferrocene Labeling of Oligonucleotides
GalNAc Labeling of Oligonucleotides
Isotope Labeling of Oligonucleotides
Methylene Blue Labeling of Oligonucleotides
Oligo Fluorescent Modifications
Psoralen Labeling of Oligonucleotides
Rhodamine Labeling of Oligonucleotides
Stearyl Labeling of Oligonucleotides
Thiol Modifiers
Tocopherol Labeling of Oligonucleotides
Oligo Modifications
Oligo Fluorescent Labeling
Oligo Backbone Modification
Oligo Base Modification
Oligo Splicing and Chemical Modification
Oligo Spacer Modification
Oligo Phosphorylation Modification
Oligonucleotide Conjugation Services
Antibiotic-Oligonucleotide Conjugation
Antibody-Oligonucleotide Conjugation
Antioxidant-Oligonucleotide Conjugation
Cell-Penetrating Peptide-Oligonucleotide Conjugation
Enzyme-Oligonucleotide Conjugation
Exosome-Oligonucleotide Conjugation
Fluorescent Molecule-Oligonucleotide Conjugation
GalNAc-Oligonucleotide Conjugation
Glycomimetic-Oligonucleotide Conjugation
Homing Peptide-Oligonucleotide Conjugation
Lipids-Oligonucleotide Conjugation
Metal Chelates-Oligonucleotide Conjugation
Nanoparticle-Oligonucleotide Conjugation
Peptide-Oligonucleotide Conjugation
Polymer-Oligonucleotide Conjugation
Protein-Oligonucleotide Conjugation
Quantum Dot-Oligonucleotide Conjugation
Small Molecule-Oligonucleotide Conjugation
Stimulus-Responsive Oligonucleotide Conjugation
Virus-Like Particle-Oligonucleotide Conjugation
Antisense Oligonucleotides Synthesis
ASO Gapmer Library Synthesis
Custom Morpholino Oligo
Gapmer Oligonucleotide Synthesis
GMP Oligonucleotide Manufacturing Services
CpG oligonucleotides (CpG ODN)
Custom LNA Synthesis
Diagnostic Probes & Oligos
Amplifluor Probes
Custom FISH Probe Service
Dual Labeled Probes
Locked Nucleic Acid (LNA) Probes
Minor Groove Binder (MGB) Probes
Peptide Nucleic Acid Probe
Scorpion Probe
TaqMan Probe Synthesis
Custom BNA Oligonucleotide Synthesis
Custom Aptamer Synthesis
Custom DNA Aptamer Synthesis
Custom RNA Aptamer Synthesis
Gene Synthesis Service
Custom PCR Primer Synthesis
RNA Drug Delivery System
Cationic Nanoemulsions
Cationic Polypeptides
Exosome
Lipid Nanoparticle
Polymer Complexes
siRNA Conjugates
Cholesterol-siRNA Conjugates
Antibody-siRNA Conjugates
Nanoparticle-siRNA Conjugates
Peptide-siRNA conjugates
Polymer-siRNA Conjugates
GalNAc-siRNA Conjugates
Aptamer-siRNA conjugates
Dynamic Polyconjugates (DPC)
Folic acid–siRNA conjugates
CpG-siRNA Conjugates
Liposomes
Oligo Analysis & Purification
Oligonucleotide Characterization Services
Oligonucleotide Stability Testing Services
Oligonucleotide Drug Release Testing Services
Fragment Analysis
RNA Extraction Service
RNA Pull Down Assay Service
In Vitro Transcription Service
Long Non-Coding RNA (LncRNA) Research
Professional Support for mRNA Vaccines
Nucleotide Modifications-Indispensable Elements for mRNA Vaccines
mRNA Capping Efficiency Assay
mRNA IVT byproduct - dsRNA Detection Service
RNA Interference Services (RNAi)
DNA-Directed RNA Interference (ddRNAi) Services
Predesigned siRNA
siRNA Design Services
RNAi Stable Cell Line Screening Services
RNAi Transfection Optimization Services
shRNA Vector Construction Services
RNAi Adenovirus Packaging Service
RNAi Lentivirus Packaging Service
shRNA Plasmid Expression Vector Construction
siRNA Interference Detection Services
mRNA Level Detection
Protein Level Detection
siRNA Synthesis Services
tRNA Services
Aminoacyl tRNA Synthetase
Aminoacyl-tRNA Pool Synthesis
Custom tRNA Synthesis
Custom Specially Modified tRNA Synthesis
Custom tRNA Synthesis with Unnatural Amino Acids
tRNA Expression Analysis
tRNA Microarray
tRNA Modification Analysis Services
tiRNA and tRF Sequencing
tRNA m
5
C Methylation Sequencing
tRNA m
7
G Modification Sequencing
tRNA Sequencing
siRNA Services
Predesigned siRNA Library
shRNA plasmid expression vector
siRNA Screening Services
Custom siRNA
Custom Chemically Modified siRNA
Base-modified siRNA
Phosphate Backbone-modified siRNA
Ribose-modified siRNA
Custom Fluorescence-labeled siRNA
siRNA Control
siRNA Sets
Custom Chimera siRNA
COVID-19 Research Support
COVID-19 mRNA Vaccine Development Services
Custom Oligo Synthesis Services For COVID-19 Research
Liposomes Drug Delivery Services For COVID-19
Products
MicroRNA Products
siRNA Products
RNA Synthesis Reagents
Cap Analogs
CPGs for oligo synthesis
Nucleosides
Nucleotides
Phosphoramidites
Liposome Products
mRNA Products
circRNA
saRNA
Support
Application Areas
FAQs
FAQs of siRNA
News
Resources
Bioinformatics Online Tools
Explore & Learn
What are Dye Phosphoramidites and Their Applications?
What are Label Phosphoramidites and Their Applications?
What are Linker Phosphoramidites and Their Applications?
What are RNA Phosphoramidites?
What are Sensitive DNA/RNA Synthesis Materials?
What are Spacer Phosphoramidites?
Webinar
Webinar: Naturally Occurring Sensitive Nucleic Acids, Applications and Chemical Synthesis
Webinar: Viral RNA Modifications and Implications for Novel Therapeutics
About Us
Events
Aptamers 2022
BOC Sciences at TIDES Europe: Oligonucleotide and Peptide Therapeutics
BOC Sciences at World Vaccine Congress Europe 2023
CPhI North America
Oligo 2022 Oxford: Antisense & Therapeutic Nucleic Acids
TIDES USA: Oligonucleotide & Peptide Therapeutics Conference
Careers
Contact Us
Get A Quote
News
Home
Support
News
Advances in siRNA Drug Research
Review: Drug delivery systems for RNA therapeutics
Update on circRNA Vaccines
mRNA vaccine expected to prevent diseases caused by ticks
Vutrisiran, The World's Fourth RNAi Therapy, Is About to Submit A Marketing Application
From COVID-19 Vaccines to Anti-Cancer Drugs, What Is the Prospect of mRNA Therapy?
Alnylam's third RNAi therapy Lumasiran was approved by the European Union for the treatment of primary hyperoxaluria type 1 (PH1)
Breaking news: RNAi can significantly inhibit hepatitis B and is expected to become a new treatment for HBV
Competing for the last mile of vaccine research and development, mRNA vaccines become a hot spot for competition
Will the mRNA vaccine become the "savior" of COVID-19?
mRNA-1647，the first infectious disease mRNA vaccine to enter the second phase of research
First RNAi treatment for inherited rare diseases
bioRxiv.: Scientists Find siRNA drugs that may inhibit SARS-CoV-2
Cell Immunity: SARS-CoV-2 vaccines status
Onpattro, The First RNAi-based therapeutic Drug
SARS-CoV-2 is undergoing mutations. Does the vaccine still work?
Application of LC-MS in the Bioassay of Oligonucleotide Drugs
GalNAc Technology for Oligonucleotide Drug Delivery
Therapeutic siRNA: Recent Advances and Prospects
Lipids Used in COVID-19 mRNA Vaccines
Vaccine Adjuvants-CpG Oligonucleotides (CpG ODN)
First LNP-mRNA In Vivo Gene Editing Therapy Reports Positive Data
First mRNA RSV Vaccine Approved for Market Release
Bridge RNA: Third-Generation Gene Editing Tool on the Horizon
Global Influenza Vaccine Market Report: Nucleic Acid Vaccines Become Mainstream
Opus Genetics Eye Gene Therapy Receives FDA Rare Pediatric Disease Designation
Breakthrough: Novartis' siRNA Therapy Achieves Phase III Success for Atherosclerotic Cardiovascular Disease
miRNA -The 2024 Nobel Prize in Physiology or Medicine Announcement
*
Only for research. Not suitable for any diagnostic or therapeutic use.
Inquiry Basket
Loading ......
Delete selected
Go to checkout
